186
Views
4
CrossRef citations to date
0
Altmetric
Original Articles

Interrupted versus continuous magnesium sulfate and blood loss at cesarean delivery

ORCID Icon, , ORCID Icon, & ORCID Icon
Pages 3853-3859 | Received 16 Aug 2020, Accepted 20 Oct 2020, Published online: 12 Nov 2020

References

  • Livingston JC, Livingston LW, Ramsey R, et al. Magnesium sulfate in women with mild preeclampsia: a randomized controlled trial. Obstet Gynecol. 2003;101(2):217–220.
  • Witlin AG, Friedman SA, Sibai BM. The effect of magnesium sulfate therapy on the duration of labor in women with mild preeclampsia at term: a randomized, double-blind, placebo-controlled trial. Am J Obstet Gynecol. 1997;176(3):623–627.
  • Coetzee EJ, Dommisse J, Anthony J. A randomised controlled trial of intravenous magnesium sulphate versus placebo in the management of women with severe pre-eclampsia. Br J Obstet Gynaecol. 1998;105(3):300–303.
  • Chen FP, Chang SD, Chu KK. Expectant management in severe preeclampsia: does magnesium sulfate prevent the development of eclampsia? Acta Obstet Gynecol Scand. 1995;74(3):181–185.
  • Ltman D, Carroli G, Duley L, et al. Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial. Lancet. 2002;359:1877–1890.
  • Gestational hypertension and preeclampsia. ACOG Practice Bulletin No. 222. American College of Obstetricians and Gynecologists. Obstet Gynecol. 2020;135:e237–60.
  • Smith JM, Lowe RF, Fullerton J, et al. An integrative review of the side effects related to the use of magnesium sulfate for pre-eclampsia and eclampsia management. BMC Pregnancy Childbirth. 2013;13:34.
  • Lu JF, Nightingale CH. Magnesium sulfate in eclampsia and pre-eclampsia: pharmacokinetic principles. Clin Pharmacokinet. 2000;38(4):305–314.
  • Belfort MA, Clark SL, Sibai B. Cerebral hemodynamics in preeclampsia: cerebral perfusion and the rationale for an alternative to magnesium sulfate. Obstet Gynecol Surv. 2006;61(10):655–665.
  • Ferris CD, Snyder SH. Inositol 1,4,5-trisphosphate-activated calcium channels. Annu Rev Physiol. 1992;54:469–488.
  • Ignaro LJ, Kadowitz PJ. The pharmacological and physiologic role of cyclic GMP in vascular smooth muscle relaxation. Annu Rev Physiol. 1985;25:171–191.
  • Karaki H. Magnesium as a modifier of smooth muscle contractility. Microcirc Endoth Lymphatics. 1989;5:77–97.
  • Young RC, Smith LH, McLaren MD. T-type and L-type calcium currents in freshly dispersed human smooth muscle cells. Am J Obstet Gynecol. 1993;169(4):785–792.
  • Graham NM, Gimovsky AC, Roman A, et al. Blood loss at cesarean delivery in women on magnesium sulfate for preeclampsia. J Matern Neonatal Med. 2016;29:1817–1821.
  • Sheiner E, Sarid L, Levy A, et al. Obstetric risk factors and outcome of pregnancies complicated with early postpartum hemorrhage: a population‐based study. J Matern Fetal Neonatal Med. 2005;18(3):149–154.
  • Combs CA, Murphy EL, Laros RK. Jr. Factors associated with postpartum hemorrhage with vaginal birth. Obstet Gynecol. 1991;77(1):69–76.
  • Combs CA, Murphy EL, Laros RK. Jr. Factors associated with postpartum hemorrhage with cesarean deliveries. Obstet Gynecol. 1991;77(1):77–82.
  • Eskild A, Vatten LJ. Abnormal bleeding associated with preeclampsia: a population study of 315,085 pregnancies. Acta Obstet Gynecol Scand. 2009;88(2):154–158.
  • Naef RW, Chauhan SP, Chevalier SP, et al. Prediction of hemorrhage at cesarean delivery. Obstet Gynecol. 1994;83(6):923–926.
  • Koopmans CM, van der Tuuk K, Groen H, et al. Prediction of postpartum hemorrhage in women with gestational hypertension or mild preeclampsia at term. Acta Obstet Gynecol Scand. 2014;93(4):399–407.
  • Al-Zirqi I, Vangen S, Forsen L, et al. Prevalence and risk factors of severe obstetric haemorrhage. BJOG. 2008;115(10):1265–1272.
  • Helman S, Drukker L, Fruchtman H, et al. Revisit of risk factors for major obstetric hemorrhage: insights from a large medical center. Arch Gynecol Obstet. 2015;292(4):819–828.
  • Dilla AJ, Waters JH, Yazer MH. Clinical validation of risk stratification criteria for peripartum hemorrhage. Obstet Gynecol. 2013;122:120–126.
  • Kramer MS, Berg C, Abenhaim H, et al. Incidence, risk factors, and temporal trends in severe postpartum hemorrhage. Am J Obstet Gynecol. 2013;209(5):449.e1–7.
  • Menard MK, Main EK, Currigan SM. Executive summary of the revitalize initiative: standardizing obstetric data definitions. Obstet Gynecol. 2014;124(1):150–153.
  • Lyndon A, Lagrew D, Shields L, Main E, Cape V, editors. Improving health care response to obstetric hemorrhage version 2.0. A California quality improvement toolkit. Stamford (CA): California Maternal Quality Care Collaborative; Sacremento (CA): California Department of Public Health; 2015.
  • Duley L, Gulmezoglu AM, Henderson-Smart DJ, et al. Magnesium sulphate and other anticonvulsants for women with pre-eclampsia. Cochrane Database of Syst Rev. 2010;11:CD000025.
  • Reale SC, Easter SR, Xu X, et al. Trends in postpartum hemorrhage in the United States from 2010 to 2014. Anesth Analg. 2020;130(5):e119–e122.
  • Taber EB, Tan L, Chao CR, et al. Pharmacokinetics of ionized versus total magnesium in subjects with preterm labor and preeclampsia. Am J Obstet Gynecol. 2002;186(5):1017–1021.
  • Tica VI, Tica AA, Carlig V, et al. Magnesium ion inhibits spontaneous and induced contractions of isolated uterine muscle. Gynecol Endocrinol. 2007;23(7):368–372.
  • Okusanya BO, Oladapo OT, Long Q, et al. Clinical pharmacokinetic properties of magnesium sulphate in women with pre-eclampsia and eclampsia. BJOG. 2016;123(3):356–366.
  • Dayicioglu V, Sahinoglu Z, Kol E, et al. The use of standard dose of magnesium sulphate in prophylaxis of eclamptic seizures: do body mass index alterations have any effect on success? Hypertens Pregnancy. 2003;22(3):257–265.
  • Vigil-DeGracia P, Ludmir J, Ng J, et al. Is there benefit to continue magnesium sulphate postpartum in women receiving magnesium sulphate before delivery? A randomised controlled study. BJOG. 2018;125(10):1304–1311.
  • Racial and ethnic disparities in obstetrics and gynecology. Committee Opinion No. 649. American College of Obstetricians and Gynecologists. Obstet Gynecol. 2015;126:e130.4.
  • Quantitative blood loss in obstetric hemorrhage. ACOG Committee Opinion No. 794. American College of Obstetricians and Gynecologists. Obstet Gynecol. 2019;134:e150–e156.
  • Diaz V, Abalos E, Carroli G. Methods for blood loss estimation after vaginal birth. Cochrane Database Syst Rev. 2018;9(9):CD010980.
  • Rubenstein AF, Zamudio S, Al-Khan A, et al. Clinical experience with the implementation of accurate measurement of blood loss during cesarean delivery: influences on hemorrhage recognition and allogeneic transfusion. Am J Perinatol. 2018;35:655.
  • Zhang WH, Deneux-Tharaux C, Brocklehurst P, et al. Effect of a collector bag for measurement of postpartum blood loss after vaginal delivery: cluster randomised trial in 13 European countries. EUPHRATES Group. BMJ. 2010;340:c293.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.